Abstract
Our recent study of the mitotic checkpoint protein BUB1 (budding uninhibited by benzimidazoles 1) revealed several apparent BUB1 knock-out cell lines expressing low levels of BUB1 protein sufficient to support spindle assembly checkpoint activity. This rings alarm bells on the application of CRISPR technology.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 1603436 |
Tidsskrift | Molecular & Cellular Oncology |
Vol/bind | 6 |
Udgave nummer | 4 |
ISSN | 2372-3556 |
DOI | |
Status | Udgivet - 4 jul. 2019 |